DNA甲基化特征区分结外NK/T细胞淋巴瘤与EBV阳性结内T/NK细胞淋巴瘤并识别预后亚组
研究对ENKTL、nodal-TNKL、ENKTL细胞系及对照组织行MeDIP-seq,发现ENKTL呈启动子广泛高甲基化伴抑癌基因沉默,nodal-TNKL呈整体低甲基化;无监督聚类识别出两个表观遗传学 distinct 的ENKTL亚组,其中高甲基化亚组伴TP53缺失、拷贝数改变及LOH增多,总生存显著更差。
要点
- ENKTL以启动子高甲基化沉默LEF1、BANK1等基因,nodal-TNKL以整体低甲基化影响细胞毒及抗原提呈通路。
- 整体DNA甲基化水平与基因组不稳定性相关。
- 高甲基化ENKTL亚组伴TP53缺失及拷贝数改变,总生存显著更差。
核心结论
- ENKTL与nodal-TNKL存在根本性表观遗传差异,DNA甲基化动态与基因组不稳定性及临床结局相关。
- 甲基化谱有助于精细分类、风险分层和治疗指导。
研究设计与样本
- 对ENKTL、nodal-TNKL、ENKTL细胞系及对照组织的FFPE样本行MeDIP-seq。
主要发现
- ENKTL显示启动子广泛高甲基化,伴LEF1、BANK1等抑癌基因、谱系调控基因及淋巴信号基因 repression,以及IFITM1等免疫和干扰素应答基因局灶低甲基化。
- nodal-TNKL显示整体低甲基化,尤其影响细胞毒性、免疫应答和抗原提呈通路;TET2突变nodal-TNKL病例表现位点特异性甲基化改变。
- 所有样本中整体DNA甲基化水平与基因组不稳定性相关。
- 无监督聚类识别两个表观遗传学 distinct 的ENKTL亚组,其中高整体甲基化亚组伴TP53缺失、拷贝数改变和杂合性缺失增多,总生存显著更差。
临床怎么用
- 甲基化谱可用于ENKTL与nodal-TNKL的鉴别诊断。
- 甲基化分型可识别高风险ENKTL亚组,辅助风险分层和治疗指导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Extranodal NK/T-cell lymphoma (ENKTL) and primary Epstein-Barr virus (EBV)-positive nodal T/NK-cell lymphoma (nodal-TNKL) are aggressive lymphomas with overlapping clinicopathologic features but distinct underlying biology. While their genomic landscapes have been increasingly defined, comparative epigenetic characterization remains limited. We performed methylated DNA immunoprecipitation sequencing (MeDIP-seq) on formalin-fixed paraffin-embedded samples from ENKTL, nodal-TNKL, ENKTL cell lines, and control tissues. ENKTL displayed extensive promoter hypermethylation associated with repression of tumor suppressor genes, lineage regulators, and lymphoid signaling genes, including LEF1 and BANK1, together with focal hypomethylation of immune- and interferon-responsive genes such as IFITM1. In contrast, nodal-TNKL showed global hypomethylation, particularly affecting cytotoxicity, immune-response, and antigen-presentation pathways; TET2-mutated nodal-TNKL cases exhibited locus-specific methylation changes. Across all samples, global DNA methylation levels correlated with genomic instability. Unsupervised clustering identified two epigenetically distinct ENKTL subgroups, one characterized by higher global methylation, TP53 loss, increased copy number alterations and loss of heterozygosity and significantly poorer overall survival. Together, this study defines fundamental epigenetic differences between ENKTL and nodal-TNKL and links DNA methylation dynamics to genomic instability and clinical outcome, highlighting the value of methylation profiling for refined classification, risk stratification and therapeutic guidance.
引用
- Phyu T, Leong SM, Chen S, et al. DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups. Leukemia. 2026. PMID: 42457877. doi:10.1038/s41375-026-03043-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。